Doxorubicin cardiotoxicity: analysis of prevailing hypotheses
Open Access
- 1 October 1990
- journal article
- review article
- Published by Wiley in The FASEB Journal
- Vol. 4 (13) , 3076-3086
- https://doi.org/10.1096/fasebj.4.13.2210154
Abstract
Anthracyclines, such as doxorubicin and daunorubicin, are highly effective anticancer agents that produce a well-described but incompletely understood cardiac toxicity. According to a popular hypothe...Keywords
This publication has 8 references indexed in Scilit:
- Role of Daunosamine and Hydroxyacetyl Side Chain in Reaction With Iron and Lipid Peroxidation by AnthracyclinesJNCI Journal of the National Cancer Institute, 1988
- Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.Proceedings of the National Academy of Sciences, 1988
- Early and delayed clinical cardiotoxicity of doxorubicinCancer, 1985
- In vivo effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and doxorubicin on the cardiac and hepatic glutathione systemsToxicology, 1985
- Doxorubicin induced alterations in lipid metabolism of cultured myocardial cellsBiochemical Pharmacology, 1985
- A protective effect of coenzyme Q10 on the adriamycin-induced cardiotoxicity in the isolated perfused rat heartJournal of Molecular and Cellular Cardiology, 1981
- Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide CineangiographyAnnals of Internal Medicine, 1981
- ELECTROLYTE AND MORPHOLOGIC ALTERATIONS OF MYOCARDIUM IN ADRIAMYCIN-TREATED RABBITS1974